U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H20O2
Molecular Weight 184.2753
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of UNDECYLENIC ACID

SMILES

OC(=O)CCCCCCCCC=C

InChI

InChIKey=FRPZMMHWLSIFAZ-UHFFFAOYSA-N
InChI=1S/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13)

HIDE SMILES / InChI

Molecular Formula C11H20O2
Molecular Weight 184.2753
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.altmedrev.com/publications/7/1/68.pdf | https://www.ncbi.nlm.nih.gov/pubmed/10991877

Undecylenic acid is unsaturated fatty acid, which naturally occurs in sweat, and is commercially produced by the vacuum distillation of castor bean oil. It is recognized as GRASE by FDA, and is marketed over the counter to treat skin infections and to relieve itching. Undecylenic acid acts by inhibition of morphogenesis from yeast to hyphae forms.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Primary
Unknown

Approved Use

Unknown
Primary
CRUEX

Approved Use

Itching, burning, redness, irritation, scaling, soreness and discomfort which may accompany these conditions
Doses

Doses

DosePopulationAdverse events​
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Sources:
unhealthy, 56 years
Health Status: unhealthy
Age Group: 56 years
Sex: M
Sources:
Disc. AE: Toxic labyrinthitis...
AEs leading to
discontinuation/dose reduction:
Toxic labyrinthitis (1 patient)
Sources:
1 g 3 times / day multiple, oral
Dose: 1 g, 3 times / day
Route: oral
Route: multiple
Dose: 1 g, 3 times / day
Sources:
unhealthy, 8-14 years
Health Status: unhealthy
Age Group: 8-14 years
Sources:
10 g 3 times / day multiple, oral
Highest studied dose
Dose: 10 g, 3 times / day
Route: oral
Route: multiple
Dose: 10 g, 3 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sources:
2 % 1 times / day multiple, topical
Dose: 2 %, 1 times / day
Route: topical
Route: multiple
Dose: 2 %, 1 times / day
Sources:
unhealthy
Health Status: unhealthy
Sources:
AEs

AEs

AESignificanceDosePopulation
Toxic labyrinthitis 1 patient
Disc. AE
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Sources:
unhealthy, 56 years
Health Status: unhealthy
Age Group: 56 years
Sex: M
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Bioconjugate functionalization of thermally carbonized porous silicon using a radical coupling reaction.
2010-12-07
Simple surface modification of poly(dimethylsiloxane) for DNA hybridization.
2010-12-06
Production of functionalized polyhydroxyalkanoates by genetically modified Methylobacterium extorquens strains.
2010-09-16
Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation.
2010-08-10
Rapid approach to biobased telechelics through two one-pot thiol-ene click reactions.
2010-06-14
Simultaneous biosynthesis of two copolymers in Pseudomonas putida GPo1 using a two-stage continuous culture system.
2010-06-14
Stimulatory effect of undecylenic acid on mouse osteoblast differentiation.
2010-04
Electrochemical behavior of gold colloidal alkyl modified silicon surfaces.
2009-11
Porous silicon for photosensitized formation of singlet oxygen in water and in simulated body fluid: two methods of modification by undecylenic acid.
2009-06
Fed-batch production of unsaturated medium-chain-length polyhydroxyalkanoates with controlled composition by Pseudomonas putida KT2440.
2009-03
Polymerizable vesicles based on a single-tailed fatty acid surfactant: a simple route to robust nanocontainers.
2009-02-03
The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors.
2009-01
Undecylenic acid: a valuable and physiologically active renewable building block from castor oil.
2009
A rapid and sensitive screening system for human type I collagen with the aim of discovering potent anti-aging or anti-fibrotic compounds.
2008-12-31
Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.
2008-11-25
Spectra and kinetic studies of the compound I derivative of cytochrome P450 119.
2008-10-08
Topographical and functional characterization of the ssDNA probe layer generated through EDC-mediated covalent attachment to nanocrystalline diamond using fluorescence microscopy.
2008-08-19
Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
2008-06
Genomic analysis of post-mating changes in the honey bee queen (Apis mellifera).
2008-05-19
A new concept in the topical treatment of onychomycosis with cyanoacrylate, undecylenic acid, and hydroquinone.
2008-04
Effect of double bonds in the formation of sodium dodecanoate and sodium 10-undecenoate mixed micelles in water.
2007-10-11
Effects of insemination quantity on honey bee queen physiology.
2007-10-03
Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent.
2007-09-05
Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on melanin synthesis.
2007-06-01
Covalent biofunctionalization of silicon nitride surfaces.
2007-05-22
Optimizing biosensing properties on undecylenic Acid-functionalized diamond.
2007-05-08
Cell adhesion properties on photochemically functionalized diamond.
2007-05-08
Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on mushroom tyrosinase.
2007-03
Mechanisms of thermal decomposition of organic monolayers grafted on (111) silicon.
2007-01-30
Structure and polymer form of poly-3-hydroxyalkanoates produced by Pseudomonas oleovorans grown with mixture of sodium octanoate/undecylenic acid and sodium octanoate/5-phenylvaleric acid.
2007-01-30
Self-assembled monolayers with latent aldehydes for protein immobilization.
2007-01-18
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles.
2007
Self-assembled thermo- and pH responsive micelles of poly(10-undecenoic acid-b-N-isopropylacrylamide) for drug delivery.
2006-12-01
3,3,5-Trimethylcyclohexanols and derived esters: green synthetic procedures, odour evaluation and in vitro skin cytotoxicity assays.
2006-12
Grazing angle mirror-backed reflection (GMBR) for infrared analysis of monolayers on silicon.
2006-09-14
Natural treatment of chronic rhinosinusitis.
2006-09
EDC-mediated DNA attachment to nanocrystalline CVD diamond films.
2006-08-15
Controlling electroosmotic flow in poly(dimethylsiloxane) separation channels by means of prepolymer additives.
2006-07-01
Simple fluorimetric liquid chromatographic method for the analysis of undecylenic acid and zinc undecylenate in pharmaceutical preparations.
2006-06-30
Synthesis and HPLC evaluation of carboxylic acid phases on a hydride surface.
2006-04
UV photodissociation spectroscopy of oxidized undecylenic acid films.
2006-03-16
Tailor-made olefinic medium-chain-length poly[(R)-3-hydroxyalkanoates] by Pseudomonas putida GPo1: batch versus chemostat production.
2006-03-05
Well-defined carboxyl-terminated alkyl monolayers grafted onto H-Si(111): packing density from a combined AFM and quantitative IR study.
2006-01-03
Silicon nanoparticles: applications in cell biology and medicine.
2006
Simple methods for the direct assembly, functionalization, and patterning of acid-terminated monolayers on Si111.
2005-11-08
Kinetic control of the photochemical reactivity of hydrogen-terminated silicon with bifunctional molecules.
2005-05-24
Synthesis, stereochemistry and biological activity of some novel long alkyl chain substituted thiazolidin-4-ones and thiazan-4-one from 10-undecenoic acid hydrazide.
2005-02
Formation, characterization, and chemistry of undecanoic acid-terminated silicon surfaces: patterning and immobilization of DNA.
2004-12-21
Surface functionalization of silicon nanoparticles produced by laser-driven pyrolysis of silane followed by HF-HNO3 etching.
2004-05-25
Screening for new compounds with antiherpes activity.
1984-10
Patents

Sample Use Guides

Undecylenic acid antifungal liquid should be applied to affected area topically.
Route of Administration: Topical
To investigate effect of undecylenic acid on Candida albicans morphogenesis, cells were grown overnight at 30°C on YPD agar and harvested by scraping the cells from the plate and suspending in YPD broth. Two milliliters of cells at 106 cells/ml was distributed into tubes containing liner, approximately 0.5 g of liner per tube. The cultures were incubated at 39°C with agitation for 2 h; planktonic cells were analyzed microscopically to determine the percentage of cells with germ tubes. The presence of Undecylenic acid inhibited the appearance of germ tubes, with 10 μM UDA causing a sevenfold reduction.
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:48:34 GMT 2025
Edited
by admin
on Mon Mar 31 17:48:34 GMT 2025
Record UNII
K3D86KJ24N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
UNDECYLENIC ACID
EP   II   INCI   JAN   MI   USP   USP-RS   VANDF   WHO-DD  
INCI  
Official Name English
UNDECYLENATE
VANDF  
Preferred Name English
10-Undecenoic acid
FHFI  
Systematic Name English
UNDECENOIC ACID
MART.  
Systematic Name English
UNDECENOIC ACID [MART.]
Common Name English
UNDECYLENIC ACID [USP MONOGRAPH]
Common Name English
UNDECYLENIC ACID [MI]
Common Name English
UNDECYLENIC ACID [II]
Common Name English
UNDECYLENIC ACID [EP MONOGRAPH]
Common Name English
UNDECYLENIC ACID [USP-RS]
Common Name English
10-UNDECENOIC ACID [FHFI]
Common Name English
UNDECYLENIC ACID [VANDF]
Common Name English
UNDECYLENIC ACID [JAN]
Common Name English
FEMA NO. 3247
Code English
NSC-2013
Code English
UNDECYLENATE [VANDF]
Common Name English
Undecylenic acid [WHO-DD]
Common Name English
Classification Tree Code System Code
DSLD 2995 (Number of products:4)
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
WHO-VATC QD01AE54
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
DSLD 3453 (Number of products:1)
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
WHO-VATC QD01AE04
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
JECFA EVALUATION 10-UNDECENOIC ACID
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
WHO-ATC D01AE04
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
CFR 21 CFR 333.210
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
WHO-ATC D01AE54
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
EPA PESTICIDE CODE 85501
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
NCI_THESAURUS C514
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID8035001
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
CAS
112-38-9
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
WIKIPEDIA
UNDECYLENIC ACID
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
RS_ITEM_NUM
1705505
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-965-8
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
CHEBI
39448
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
SMS_ID
100000091959
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
DAILYMED
K3D86KJ24N
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
FDA UNII
K3D86KJ24N
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
DRUG CENTRAL
3446
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
CHEBI
35045
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
RXCUI
10989
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
EVMPD
SUB15654MIG
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
MESH
C538763
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
RXCUI
314881
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
ALTERNATIVE
NCI_THESAURUS
C29530
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
MERCK INDEX
m11303
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY Merck Index
JECFA MONOGRAPH
373
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
ChEMBL
CHEMBL1276010
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
NSC
2013
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
DRUG BANK
DB11117
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
PUBCHEM
5634
Created by admin on Mon Mar 31 17:48:34 GMT 2025 , Edited by admin on Mon Mar 31 17:48:34 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY